Among Migrating Nurses, Survey Shows High Satisfaction Rates for Those Who Use a Certified Ethical Recruiter
Sep 12, 2025 05:00 HKT |  |
|
AGFA HealthCare Strengthens Market Position in KLAS Enterprise Imaging Report 2025
Sep 11, 2025 04:00 HKT |  |
|
Elevating Imaging, Empowering Flow - AGFA HealthCare at RSNA 2025
Sep 09, 2025 16:00 HKT | |
|
Sichuan Neautus TCM Files for Hong Kong IPO to Accelerate Domestic and Global Expansion
Sep 03, 2025 16:33 HKT | |
|
Everest Medicines Announces 2025 Interim Results: 'Dual-Engine' Strategy Driving Strong Synergies Between Commercialization and R&D
Sep 01, 2025 20:55 HKT |  |
|
Fosun's Bold Innovation & Globalization Drive Valuation Upside
Aug 29, 2025 10:14 HKT | |
|
Modern Dental Group Reports 34.7% Surge in 1H2025 Net Profit
Aug 29, 2025 09:25 HKT |  |
|
Yunkang Group's 2025 Interim Net Loss Narrows, Demonstrating Strong Operational Resilience
Aug 29, 2025 00:02 HKT |  |
|
Hua Medicine Announces 2025 Interim Results
Aug 28, 2025 17:07 HKT |  |
|
Formerra Appointed Distributor for Italy's Epaflex TPU Lines in the UK & Ireland
Aug 27, 2025 21:00 HKT |  |
|
Resilient Interim Results, Essex Bio-Technology Drives Growth and Innovation
Aug 26, 2025 20:00 HKT |  |
|
Lepu Biopharma (2157.HK) announces 2025 interim results
Aug 21, 2025 14:38 HKT |  |
|
Innovative Vaccine Engine Continues to Drive Growth: CanSinoBIO Enters a New Growth Cycle
Aug 20, 2025 20:30 HKT |  |
|
Australian Breakthrough by Cholrem: Cyclodextrin Therapy Reverses Heart Disease, Hailed as Greatest Advance Since Statins
Aug 19, 2025 21:00 HKT |  |
|
CMS (867.HK, 8A8.SG) Reports Growth in Revenue and Profit for H1 2025, Strategic Transformation Unlocks New Drivers
Aug 19, 2025 15:00 HKT |  |
|
Etrasimod Receives Strong Recommendation in the ACG Clinical Guideline Update: Ulcerative Colitis in Adults for Induction and Maintenance Phase of Moderately to Severely Active UC
Aug 15, 2025 20:15 HKT | |
|
OrbusNeich Records Growth in 2025 Interim Results, Revenue and Net Profit Reach US$83.6 Million and US$19.8 Million Respectively
Aug 15, 2025 19:11 HKT |  |
|
Everest Medicines' New Drug Application for Etrasimod Accepted in Taiwan, Marking Another Milestone in Asia Market Access
Aug 14, 2025 18:00 HKT | |
|
NMPA Accepted Essex's Biologics License Application for EB12-20145P (HLX04-O) for the Treatment of Wet Age-Related Macular Degeneration
Aug 13, 2025 20:24 HKT | |
|
AsiaMedic Reports 26% Revenue Growth to S$16.6 million in 1H2025, Led by Strong Diagnostic Imaging Performance
Aug 13, 2025 14:00 HKT |  |
|